Latest Cancer News

Keytruda Approved for Treatment of Stage III Melanoma (02-21-2019)
The U.S. Food and Drug Administration (FDA) has approved Keytruda for the adjuvant treatment of patients with melanoma with involvement of lymph node(s) following complete surgical resection. Adjuvant... Continue Reading

FDA Approves Nivolumab and Ipilimumab Combination for Advanced Kidney Cancer (02-18-2019)
The Food and Drug Administration (FDA) approved the immunotherapy drugs Opdivo and Yervoy in combination as an initial, or first-line, treatment for patients with advanced kidney cancer whose disease has... Continue Reading

Keytruda Plus Inlyta Improves Survival Compared ot Sutent for Treatment of Advanced Kidney Cancer (02-18-2019)
Results from the randomized, phase III KEYNOTE-426 clinical trial show that first-line therapy with a combination of the PD-1 targeted immunotherapy Keytruda (pembrolizumab) and the VEGF-targeted tyrosine... Continue Reading

More Cancer News

Patient Resources

VirtualTour_280x99

CoC Logo 541 ACCREDITED PROGRAM caps